Found: 16
Select item for more details and to access through your institution.
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 615, doi. 10.1002/ajh.27246
- By:
- Publication type:
- Article
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 272, doi. 10.1002/ajh.26771
- By:
- Publication type:
- Article
Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re‐induction chemotherapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 245, doi. 10.1002/ajh.25692
- By:
- Publication type:
- Article
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1358, doi. 10.1002/ajh.25256
- By:
- Publication type:
- Article
Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2414425, doi. 10.1001/jamanetworkopen.2024.14425
- By:
- Publication type:
- Article
Monosomal Karyotype Acute Myeloid Leukemia: Tread Lightly.
- Published in:
- Acta Haematologica, 2015, v. 133, n. 4, p. 324, doi. 10.1159/000368213
- By:
- Publication type:
- Article
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 364, doi. 10.1016/j.clml.2024.01.007
- By:
- Publication type:
- Article
MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S343, doi. 10.1016/S2152-2650(21)01798-5
- By:
- Publication type:
- Article
Poster: MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01429-4
- By:
- Publication type:
- Article
New era for myelofibrosis treatment with novel agents beyond Janus kinase‐inhibitor monotherapy: Focus on clinical development of BCL‐X<sub>L</sub>/BCL‐2 inhibition with navitoclax.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3535, doi. 10.1002/cncr.34986
- By:
- Publication type:
- Article
Defining disease modification in myelofibrosis in the era of targeted therapy.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2420, doi. 10.1002/cncr.34205
- By:
- Publication type:
- Article
PhALLCON Soars to New Heights—Faster, Stronger, but Better?
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1805, doi. 10.1001/jama.2024.5871
- By:
- Publication type:
- Article
Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1359113
- By:
- Publication type:
- Article
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 728, p. 1, doi. 10.1126/scitranslmed.ade2774
- By:
- Publication type:
- Article
Regulation of Ribosomal Gene Expression in Cancer.
- Published in:
- Journal of Cellular Physiology, 2015, v. 230, n. 6, p. 1181, doi. 10.1002/jcp.24854
- By:
- Publication type:
- Article
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies.
- Published in:
- Acta Haematologica, 2024, v. 147, n. 2, p. 200, doi. 10.1159/000533990
- By:
- Publication type:
- Article